Prenatal treatment of congenital toxoplasmosis could reduce the risk of brain damage

Oct 12, 2010

Prenatal treatment of congenital toxoplasmosis with antibiotics might substantially reduce the proportion of infected fetuses that develop serious neurological sequelae (brain damage, epilepsy, deafness, blindness, or developmental problems) or die, and could be particularly effective in fetuses whose mothers acquired Toxoplasma gondii, the parasite that causes toxoplasmosis, during the first third of pregnancy. These are the findings of an observational study by Ruth Gilbert from the UCL Institute of Child Health, London, UK, and colleagues and published in this week's PLoS Medicine.

Toxoplasmosis is a very common but most infected people never know they have the disease. However, about a quarter of women who are infected with toxoplasmosis during pregnancy transmit the parasite to their . The authors followed 293 children in six European countries in whom congenital toxoplasmosis had been identified by (France, Austria, and Italy) or by neonatal screening (in Denmark, Sweden, and Poland). Two-thirds of the children received prenatal treatment for toxoplasmosis with the antibiotics spiramycin or pyrimethamine-sulfonamide.

23 (8% of the fetuses) developed serious neurological sequelae or died, nine of which were terminated during pregnancy. By comparing the number of children who had serious neurological sequelae who received prenatal treatment with the number among children who did not receive prenatal treatment, the authors estimated that prenatal treatment of congenital toxoplasmosis reduced the risk of serious neurological sequelae by three-quarters. Furthermore, they found that to prevent one case of serious neurological sequelae after maternal infection at 10 weeks of pregnancy, it would be necessary to treat three fetuses with confirmed infection and to prevent one case of SNSD after maternal infection at 30 weeks of pregnancy, 18 infected fetuses would need to be treated. The authors also found that that the effectiveness of the antibiotics used, pyrimethamine-sulfonamide and the less toxic spiramycin, was similar.

The authors explain how these results should be interpreted. They conclude: "The finding that prenatal treatment reduced the risk of [serious neurological sequelae] in infected fetuses should be interpreted with caution because of the low number of [serious neurological sequelae] cases and uncertainty about the timing of maternal seroconversion." The authors add: "As these are observational data, policy decisions about screening require further evidence from a randomized trial of prenatal screening and from cost-effectiveness analyses that take into account the incidence and prevalence of maternal infection."

Explore further: Obama addresses West Africans on facts about Ebola

More information: Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, et al. (2010) Prenatal Treatment for Serious Neurological Sequelae of Congenital Toxoplasmosis: An Observational Prospective Cohort Study. PLoS Med 7(10): e1000351. doi:10.1371/journal.pmed.1000351

add to favorites email to friend print save as pdf

Related Stories

Toxoplasmosis found more severe in Brazil compared to Europe

Aug 14, 2008

Newborns in Brazil are more susceptible to toxoplasmosis than those in Europe, according to a recent study. Researchers based in Austria, Brazil, Denmark, France, Italy, Poland, Sweden, and the United Kingdom studied the ...

Toxoplasmosis infection trick revealed by scientists

May 10, 2007

Toxoplasmosis is a parasitic disease, primarily carried by cats. It is transmitted to humans by eating undercooked meat or through contact with cat faeces. It is particularly dangerous for pregnant women, whose foetuses can ...

Recommended for you

Obama addresses West Africans on facts about Ebola

6 hours ago

President Barack Obama urged West Africans on Tuesday to wear gloves and masks when caring for Ebola patients or burying anyone who died of the disease. He also discouraged the traditional burial practice ...

Gluten-free diet benefits asymptomatic EmA+ adults

7 hours ago

(HealthDay)—Asymptomatic individuals with endomysial antibodies (EmA) benefit from a gluten-free diet (GFD), according to a study published in the September issue of Gastroenterology.

Another US health worker infected with Ebola

7 hours ago

A third American health worker has tested positive for the Ebola virus while working with patients in West Africa, the Christian missionary group SIM said Tuesday.

UN implores all countries to help on Ebola

9 hours ago

The international group Doctor Without Borders warned Tuesday that the world is 'losing the battle' against Ebola, while U.N. officials implored all countries to quickly step up their response by contributing health experts ...

Travel restrictions could worsen Ebola crisis: experts

13 hours ago

Travel restrictions could worsen West Africa's Ebola epidemic, limiting medical and food supplies and keeping out much-needed doctors, virologists said Tuesday as the disease continued its deadly spread.

User comments : 0